Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Hepatitis C

  Free Subscription


13.01.2020

1 BMC Gastroenterol
2 Eur J Gastroenterol Hepatol
1 J Hepatol
1 J Infect Dis
2 J Viral Hepat
5 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. LIAO YH, Hsu RJ, Wang TH, Wu CT, et al
    Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
    BMC Gastroenterol. 2020;20:6.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. HASSANIN TM, Abdelraheem EM, Abdelhameed S, Abdelrazik M, et al
    Detection of hepatitis C virus core antigen as an alternative method for diagnosis of hepatitis C virus infection in blood donors negative for hepatitis C virus antibody.
    Eur J Gastroenterol Hepatol. 2019 Dec 31. doi: 10.1097/MEG.0000000000001647.
    PubMed     Text format     Abstract available

  3. RAMACHANDRAN J, Kaambwa B, Muller K, Haridy J, et al
    Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience.
    Eur J Gastroenterol Hepatol. 2019 Dec 31. doi: 10.1097/MEG.0000000000001659.
    PubMed     Text format     Abstract available


    J Hepatol

  4. EVON DM, Sarkar S, Amador J, Lok AS, et al
    Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
    J Hepatol. 2019 Dec 27. pii: S0168-8278(19)30702.
    PubMed     Text format    


    J Infect Dis

  5. CLIPMAN SJ, Duggal P, Srikrishnan AK, Saravanan S, et al
    Prevalence and phylogenetic characterization of hepatitis C among men who have sex with men in India: limited evidence for sexual transmission.
    J Infect Dis. 2020 Jan 9. pii: 5699640. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Viral Hepat

  6. FEDORCHENKO SV, Martynovych T, Klimenko Z, Yanchenko V, et al
    Retreatment of patients with chronic hepatitis C, subtype 1b and cirrhosis, who failed previous direct acting antiviral therapy including first- and second-generation NS5A inhibitors with ombitasvir/ paritaprevir/ ritonavir, dasabuvir + sofosbuvir + r
    J Viral Hepat. 2020 Jan 2. doi: 10.1111/jvh.13254.
    PubMed     Text format     Abstract available

  7. YAMAMICHI S, Miuma S, Wada T, Masumoto H, et al
    Deep sequence analysis of NS5A resistance-associated substitution changes in patients reinfected with the hepatitis C virus after liver transplantation.
    J Viral Hepat. 2020 Jan 2. doi: 10.1111/jvh.13256.
    PubMed     Text format     Abstract available


    PLoS One

  8. RIVERO-JUAREZ A, Guijo-Rubio D, Tellez F, Palacios R, et al
    Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals.
    PLoS One. 2020;15:e0227188.
    PubMed     Text format     Abstract available

  9. TSAI WL, Wang CF, Cheng JS, Chen WC, et al
    Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience.
    PLoS One. 2020;15:e0227424.
    PubMed     Text format     Abstract available

  10. SHAO LN, Zhang ST, Wang N, Yu WJ, et al
    Platelet indices significantly correlate with liver fibrosis in HCV-infected patients.
    PLoS One. 2020;15:e0227544.
    PubMed     Text format     Abstract available

  11. GOOD SS, Moussa A, Zhou XJ, Pietropaolo K, et al
    Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
    PLoS One. 2020;15:e0227104.
    PubMed     Text format     Abstract available

  12. NUTINI MFR, Hunter J, Giron L, Pires AFNPC, et al
    HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country.
    PLoS One. 2020;15:e0227082.
    PubMed     Text format     Abstract available


    Transplant Proc

  13. BAYRAKTAR A, Akgul SU, Bakkaloglu H, Temurhan S, et al
    Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
    Transplant Proc. 2019 Dec 31. pii: S0041-1345(19)30884.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: